MAM
L’Oreal India appoints Amit Jain as managing director
MUMBAI: L’Oreal India has appointed Amit Jain as a new India managing director succeeding Jean Christophe Letellier who will shift within L’Oréal group after a five-year stint in the country.
L’Oreal is one of the largest cosmetics company and has developed activities in the field of hair colour, skin care, sun protection and many others.
Jain will join the company from August this year and will be the first Indian MD after the French cosmetics giant entered in 1991.
L’Oreal South Asia Pacific Zone vice president Pierre-Yves Arzel said, “We believe that Amit’s rich global experience with a deep understanding of India, transformational leadership skills and inclusive personality will be an important asset in further developing L’Oréal’s business in India. His mission is to build on our rich talent base and global brands, to make L’Oréal India an engine for growth in Asia,”
Prior to this, Jain was the managing director of North-West Europe for Akzo Nobel, based in Amsterdam. Jain has also worked in companies including Coca- Cola and Viacom.
Under Jean-Christophe Letellier’s leadership, India saw significant sales growth, revolutionised digital and e-commerce platforms, and achieved ambitious targets in skill development and environmental sustainability.
The company, which is almost synonymous with Bollywood actress and its brand ambassador Aishwarya Rai Bachchan in India, face competition from global rivals Unilever and Procter and Gamble
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
